SCHEMBL16014105

SCHEMBL16014105

N#Cc1c(N)nc2c(c1-c1ccccc1F)CCCC2

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 18/20 0.68
HSD17B10 Q99714 6/20 0.68
ALDH1A1 P00352 12/20 0.65
ADORA2A P29274 2/20 0.64
SMN1; SMN2 Q16637 1/20 0.64
HPGD P15428 11/20 0.60
MEN1 O00255 1/20 0.60
KMT2A Q03164 1/20 0.60
NPSR1 Q6W5P4 1/20 0.58
CYP1A2 P05177 3/20 0.58
CYP2C9 P11712 3/20 0.58
CYP2C19 P33261 3/20 0.58
HTT P42858 2/20 0.57
TSHR P16473 2/20 0.57
CYP3A4 P08684 2/20 0.56
MDM2 Q00987 1/20 0.56
USP2 O75604 2/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
NPC1 O15118 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6254905 0.86 KDM4E (0.70) KDM4EHSD17B10ALDH1A1ADORA2ASMN1; SMN2
SCHEMBL6252358 0.81 KDM4E (1.00) KDM4EHSD17B10ALDH1A1ADORA2ASMN1; SMN2
SCHEMBL17351373 0.80 KDM4E (0.97) KDM4EHSD17B10ALDH1A1ADORA2ASMN1; SMN2
SCHEMBL16014103 0.80 ADORA2A (0.52) KDM4EHSD17B10ALDH1A1ADORA2ASMN1; SMN2
SCHEMBL1177057 0.79 KDM4E (1.00) KDM4EHSD17B10ALDH1A1ADORA2ASMN1; SMN2
SCHEMBL6251113 0.78 HPGD (0.70) KDM4EHSD17B10ALDH1A1ADORA2ASMN1; SMN2
SCHEMBL6252484 0.78 KDM4E (0.73) KDM4EHSD17B10ALDH1A1ADORA2ASMN1; SMN2
SCHEMBL17351623 0.76 ALDH1A1 (0.52) KDM4EHSD17B10ALDH1A1ADORA2ASMN1; SMN2
SCHEMBL6255004 0.75 HPGD (0.52) KDM4EHSD17B10ALDH1A1ADORA2ASMN1; SMN2
SCHEMBL31120389 0.75 KDM4E (0.78) KDM4EHSD17B10ALDH1A1ADORA2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2964644-A1 PERFLUORINATED CYCLOPROPYL FUSED 1,3-OXAZIN-2-AMINE COMPOUNDS AS BETA-SECRETASE INHIBITORS AND METHODS OF USE Amgen Inc. (US) 2016-01-13 EP disclosed
WO-2014138484-A1 PERFLUORINATED CYCLOPROPYL FUSED 1,3-OXAZIN-2-AMINE COMPOUNDS AS BETA-SECRETASE INHIBITORS AND METHODS OF USE AMGEN INC. (US) 2014-09-12 WO disclosed